Isis Pharmaceuticals has started a Phase 1 trial to evaluate ISIS-PTP1BRx as a treatment for type 2 diabetes patients whose glucose is inadequately controlled by insulin or oral therapies. The antisense drug ISIS-PTP1BRx is intended to increase the
Isis Pharma Starts Phase 1 Type 2 Diabetes Drug Trial
Related posts:
- Sanofi Phase III Success With GLP 1 Drug For Type 2 Diabetes Sanofi says its GLP-1 drug, lixisenatide, performed well again in...
- Lorcaserin Phase 3 Trial Data On Type 2 Diabetes To Be Presented Amylin gets European approval for weekly diabetes drug Bydureon, which...
- Abbott Reveals Positive Results From Phase 2 Trial Of Kidney Drug (RTTNews) – Abbott Laboratories (ABT: News ), said Friday that...
- New Bardoxolone Methyl Phase 2 Trial Data On Kidney Disease Diabetes Presented At ERA EDTA 2011 New Phase 2 clinical trial data published online today in...
- Preliminary Results From Generex Oral Lyn Clinical Trial On Type 1 Diabetes While equally important in both type 1 and type 2...